CITRAVESCENT granules sachet (reformulation)

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

sodium bicarbonate, Quantity: 1.32 g; citric acid, Quantity: 1.23 g; tartaric acid, Quantity: 0.4 g; sodium carbonate, Quantity: 0.08 g

Tillgänglig från:

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

INN (International namn):

citric acid,sodium bicarbonate,sodium carbonate,tartaric acid

Läkemedelsform:

Granules, effervescent

Sammansättning:

Excipient Ingredients: lactose monohydrate; sucrose

Administreringssätt:

Oral

Enheter i paketet:

8 sachets, 10 sachets, 25 sachets, 28 sachets, 20 sachets

Receptbelagda typ:

Not scheduled. Not considered by committee

Terapeutiska indikationer:

Systemic and urinary alkalinisation where indicated in the relief of symptoms associated with urinary tract infections such as cystitis, pyelonephritis, urethritis; and in reducing the formation of uric acid and cystine calculi. Citravescent may increase the effectiveness of sulphonamide antibiotics in the treatment of urinary tract infection. Acid indigestion or heartburn.

Produktsammanfattning:

Visual Identification: White granules; Container Type: Sachet; Container Material: Al laminated with LDPE/paper; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Bemyndigande status:

Licence status A

Tillstånd datum:

2013-08-15